Live from the NIH registry
Studies recruiting near Tempe right now
Top 25 of 1,433 recruiting studies, sorted by proximity — each links to its official registry page
Shared Decision Making to Improve Goals of Care in the ED
Goals
N/A
Interventional 230 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (8.6 mi)
· Sponsor: Mayo Clinic
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (9.2 mi)
· Sponsor: National Cancer Institute (NCI)
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 200 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (8.6 mi)
· Sponsor: Mayo Clinic
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
Bone Graft; Complications, ACL Injuries
N/A
Interventional 75 participants sought
Banner Sports Medicine Scottsdale — Scottsdale, Arizona (8.6 mi)
· Sponsor: University of Arizona
Early Tracking of Childhood Health Determinants (ETCHED) Study
Diabetes Mellitus, Obesity
N/A
Observational 1,500 participants sought
NIDDK, Phoenix — Phoenix, Arizona (9.2 mi)
· Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona (8.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 — Phoenix, Arizona (9.2 mi)
· Sponsor: Sanofi
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (9.2 mi)
· Sponsor: Rejoni Inc.
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Ironwood Cancer & Research Centers — Chandler, Arizona (7.7 mi)
· Sponsor: Guardant Health, Inc.
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Colorectal Carcinoma
N/A
Interventional 450 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (8.6 mi)
· Sponsor: Mayo Clinic
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Phoenix, Arizona (9.2 mi)
· Sponsor: AstraZeneca
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (9.2 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Center at Saint Joseph's — Phoenix, Arizona (9.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
GI Alliance Sun City — Sun City, Arizona (24.4 mi)
· Sponsor: Takeda
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Phase 2
Interventional 204 participants sought
GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400003 — Sun City, Arizona (24.4 mi)
· Sponsor: Sanofi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Banner MD Anderson Cancer Center — Gilbert, Arizona (8.6 mi)
· Sponsor: Relay Therapeutics, Inc.
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
Mayo Clinic Arizona — Scottsdale, Arizona (8.6 mi)
· Sponsor: Tr1X, Inc.
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Barrow Neurological Institute at St. Joseph's Hospital — Phoenix, Arizona (9.2 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Mayo Clinic Hospital in Arizona — Phoenix, Arizona (9.2 mi)
· Sponsor: NRG Oncology
Light Exposure, Migraine Outcomes, and Sleep Quality
Migraine Headache, Sleep
N/A
Interventional 20 participants sought
ASU DeSmart Lab — Tempe, Arizona (2.3 mi)
· Sponsor: Arizona State University
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Advanced Liver Cancer
Phase 1
Interventional 200 participants sought
Mayo Clinic — Phoenix, Arizona (9.2 mi)
· Sponsor: Abbisko Therapeutics Co, Ltd
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring, Fragility Fracture
N/A
Interventional 48 participants sought
University of Arizona — Phoenix, Arizona (9.2 mi)
· Sponsor: University of Southern California
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Mesa, Arizona (6.7 mi)
· Sponsor: Pfizer
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Mayo Clinic — Scottsdale, Arizona (8.6 mi)
· Sponsor: Takeda
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome
N/A
Interventional 2,000 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (8.6 mi)
· Sponsor: Mayo Clinic